The pros from PureTech Ventures (Boston), Accelerator Corp (Seattle) and BioAdvance (Philadelphia) spent some time yesterday setting the table of today’s current early-stage biotech investing climate and proceeded to illuminate some absolutely critical elements to incorporate while on the fund-raising trail. Without a doubt the present day funding gap or ‘valley of death’ is real [...]